LAMIVUDINE
Tracking # 20-1145260
Course overview
LAMIVUDINE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HIV-1 AND HEPATITIS B. IT IS IN THE NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI) CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS FOR LAMIVUDINE AS A VALUABLE AGENT IN THE THERAPY FOR HIV (AND OTHER DISORDERS WHEN APPLICABLE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE CARE OF PATIENTS WITH HIV AND HEPATITIS B.
Subject areas
This course counts toward the state boards and subject areas below.